Showing results (1631-1640 of 1,715) with videos related to

Sort By:
Pageof 172
JAMA Oncology|July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 StudyJoe Y Chang, Vivek Verma, Ming Li, et al.
ACS Pharmacology & Translational Science|August 23, 2021
Human Islet Expression Levels of Prostaglandin E<sub>2</sub> Synthetic Enzymes, But Not Prostaglandin EP3 Receptor, Are Positively Correlated with Markers of β-Cell Function and Mass in Nondiabetic ObesityNathan A Truchan, Rachel J Fenske, Harpreet K Sandhu, et al.
Journal of Medicinal Chemistry|January 10, 2023
Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of SchizophreniaMark E Layton, Jeffrey C Kern, Timothy J Hartingh, et al.
Molecular Metabolism|August 28, 2018
Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetesAli J Chakera, Paul S Hurst, Gill Spyer, et al.
Science Signaling|September 28, 2017
Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodiesAndrew M Waters, Irem Ozkan-Dagliyan, Angelina V Vaseva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2018
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung CancerZhongxing Liao, J Jack Lee, Ritsuko Komaki, et al.
Science Signaling|July 18, 2019
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancerDevon R Blake, Angelina V Vaseva, Richard G Hodge, et al.
Infection and Immunity|July 31, 2025
Tick-borne coinfections modulate CD8<sup>+</sup> T cell response and progressive leishmaniosisBreanna M Scorza, Danielle Pessôa-Pereira, Felix Pabon-Rodriguez, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
Metabolites|January 20, 2021
Systemic Metabolic Alterations Correlate with Islet-Level Prostaglandin E<sub>2</sub> Production and Signaling Mechanisms That Predict β-Cell Dysfunction in a Mouse Model of Type 2 DiabetesMichael D Schaid, Yanlong Zhu, Nicole E Richardson, et al.
Pageof 172